Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-07-30
2011-10-04
Shafer, Shulamith H (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S002000, C435S007100, C435S810000, C435S320100, C536S023400
Reexamination Certificate
active
08030016
ABSTRACT:
The present invention relates to a screening method for a compound and includes a step of detecting binding between a vitamin D receptor and CDP. A novel method enabling screening in vitro of a compound having strong bone forming action and low side effects, a compound participating in osteoblast differentiation and selected by the method of screening, a therapeutic agent containing the compound for diseases intervening in the increase in vitamin D-mediated transcriptional activity by a complex of a vitamin D receptor and CDP, and a kit for performing the screening method are provided.
REFERENCES:
patent: 5578708 (1996-11-01), Okazaki et al.
patent: 2005/0042730 (2005-02-01), Kato et al.
patent: 00/15836 (2000-03-01), None
patent: 2004/045371 (2004-06-01), None
Y. Ma, et al., “Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators,” Journal of Clinical Investigation, 2006, pp. 892-904, vol. 116, No. 4.
M.F. Van Gurp, et al., “The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A,” Cancer Research, 1999, pahes 5980-5988, vol. 59.
A. Nepveu, “Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development,” Gene, 2001, pp. 1-15, vol. 270. No. 1-2.
S. Nagpal, et al., “Noncalcemic actions of vitamin D receptor ligands,” Endocrine Reviews, 2005, pp. 662-687, vol. 26, No. 5.
European Search Report dated Jan. 29, 2010, as issued in European Application No. 07791983.5.
Shalnik, et al., “CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter”, The Journal of Biological Chemistry, vol. 266, No. 25, pp. 16736-16744, 1991.
Balint, et al., “Phenotype discovery by gene expression profiling: Mapping of biological processes linked to BMP-2-mediated osteoblast differentiation”, Journal of Cellular Biochemistry, Wiley-Liss, Inc., vol. 89, No. 2, pp. 401-426, May 15, 2003.
Ochiai, et al., “Identification of osteoblast-specific co-regulator complex for vitamin D receptor (VDR)”, Journal of Bone and Mineral Research, American Society for Bone and Mineral Research, vol. 21, No. Suppl. 1, p. S460, Sep. 1, 2006.
Matsumoto et al., Stimulation by 1, 25-Dihydroxy D3of in Vitro Mineralization Induced by Osteoblast-like MC3T3-E1 Cells, Bone vol. 12, 27-32, (1991).
Oda A. et al., Two Distinct Coactivators, DRIP/Mediator and SRC/p 160, Are Differentially Involved in Vitamin D Receptor Transactivation during Keratinocyte Differentiation, Mol. Endocrinol, vol. 17, 2329-2339 (2003).
Neufeld E. J. et al., Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut, (1992), Nature. Genet. 1. 50-55.
Andres. V. et al.,Clox, a mammalian homeobox gene relates toDrosophila cut, encodes DNA-binding regulatory proteins differentially expressed during development, (1992) Development. 116, 321-334.
Valarche I et al., The mouse homeodomain protein Phox2 regulatesNcampromoter activity in concert with Cux/CDP and is a putative determinant of neurotransmitter phenotype, (1993) Development 119, 881-896.
Yoon S.O. et al., Isolation of Two E-box Binding Factors That Interact with the Rat Tyrosine Hydroxylase Enhancer, (1994) J. Biol. Chem., 269, 18453-18462.
Alain Nepveu, Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development, (2001), Gene 270: 1-15.
Jack et al., Expression of the cut locus in the Drosophila wing margin is required for cell type specification and is regulated by a distant enhancer, (1991), Development, 113:735-747.
Ellis et al., The transcriptional repressor CDP(Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle, Genes & Development, 15:2307-2319, (2001).
Ledford et al., Deregulated Expression of the Homeobox Gene Cux-1 in Transgenic Mice Results in Downregulation of p27kiplExpression during Nephrogenesis, Glomerular Abnormalities, and Multiorgan Hyperplasia, (2002), Developmental Biology, 245:157-171.
Holthuis et al. Tumor Cells Exhibit Deregulation of the Cell Cycle Histone Gene Promoter Factor HiNF-D, (1990), Science, 247:1454-1457.
Pattision et al., CCAAT Displacement Protein, a Regulator of Differentiation-Specific Gene Expression, Binds a Negative Regulatory element within the 5′ End of the Human Papillomavirus Type 6 Long Control Region, (1997) Journal of Virology, vol. 71, No. 3, 2013-2022.
Liu et al. The Matrix Attachment Region-Binding Protein SATB1 Participates in Negative Regulation of Tissue-Specific Gene Expression, (1997), Molecular and Cellular, Biology, vol. 17, No. 9, 5275-5287.
Burglin et al. Loss and gain of domains during evolution of cut superclass homeobox genes, (2002), Int. J. Dev. Biol., 46:115-123.
Dickinson et al., An Atypical Homeodomain in SATB1 Promotes Specific Recognition of the key Structural Element in a Matrix Attachment Region, (1997), Journal of Biological Chemistry, vol. 272, No. 17, 11463-11470.
Moon et al., CCAAT Displacement Activity Involves CUT Repeats 1 and 2, Not the CUT Homeodomain, (2000), Journal of Biological Chemistry, vol. 275, No. 40, 31325-31334.
Moon et al., S Phase-Specific Proteolytic Cleavage Is Required to Activate Stable DNA Binding by the CDP/ Cut Homeodomain Protein, (2001) Molecular and Cellular Biology, vol. 21, No. 18, 6332-6345.
Wang et al., Cux/CDP Homeoprotein Is a Component of NF-μNR and Represses the Immunoglobulin Heavy Chain Intronic Enhancer by Antagonizing the Bright Transcription Activator, (1999) Molecular and Cellular Biology, vol. 19, No. 1, 284-295.
Kato Shigeaki
Kitagawa Hirochika
Ochiai Eiji
Takada Ichiro
Takagi Ken-ichiro
Shafer Shulamith H
Sughrue & Mion, PLLC
Teijin Pharma Limited
The University of Tokyo
LandOfFree
Method for screening for vitamin D receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for screening for vitamin D receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for screening for vitamin D receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4265580